RespireRx Pharmaceuticals Inc (RSPI)

[atheroprevent]

Thanks myostrain, well stated.

I agree, enemem, pure central sleep apnea is not common and more likely seen in post stroke and chronic heart failure. The benefit in upregulating respiratory tonic pathways. however, must impact the spectrum of obstructive sleep apnea.

I understand Medicare is looking at approving home sleep apnea testing. This would potentially reduce the barrier to diagnosis and would shift treatment to a larger group of primary care physicians and drive the market potential of ampakines for sleep apnea.

Just an anecdotal case........ last night one of my partners was called in to transfer a patient to the intensive care unit. The patient had abdominal surgery and after 4 hours of observation in the recovery room the patient was "still breathing slowly". Narcan was obviously not a treatment option after surgery. An ampakine for RD would have probably reduced cost and length of hospital stay and would have restored at least 2 hours of quality sleep that my partner lost.